Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $14
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $13 to $14.
Equity
Viatris Inc. (VTRS) Stock — Today's Move
$18.29
+$0.29 today
VTRS is up 1.61% today. Volume is 6.06M vs a 30-day average of 9.22M (0.66x).
Day High
$18.40
Day Low
$18.11
Open
$18.20
Prev Close
$18.00
Volume
6.06M
Avg Vol (30d)
9.22M
52-Wk High
$18.75
52-Wk Low
$9.92
Sector
—
Today's Move
+1.61%
Next Earnings
Thu, Nov 5
Viatris Inc. is scheduled to report earnings Thu, Nov 5, 2026. Analysts expect EPS of $0.65 on revenue of about $3.88B. Stocks often move sharply on earnings day.
52-wk low $9.9252-wk high $18.75
VTRS is 95% of the way from its 52-week low to its high.
Indicators:
Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.
Why is VTRS moving today?
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Viatris (NASDAQ:VTRS) Vs The Rest Of The Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how generic pharmaceuticals stocks fared in Q2, …
JP Morgan Maintains Neutral on Viatris, Raises Price Target to $20
JP Morgan analyst Chris Schott maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $18 to $20.
Viatris’ Dividend Has Room to Grow, but Will Management Deliver?
Viatris Inc. (NASDAQ:VTRS) is a familiar name in the pharmaceutical industry, with a portfolio that stretches from branded medications to generics and fresh, innovative therapies.…
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine ophthalmic solution …
Related Movers
XP
▼ -48.36%
XP Inc.
Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Session
$15.71
-$14.71
INTR
▼ -34.91%
Inter & Co. Inc.
S&P Index Addition Could Change The Case For Inter (INTR) Stock
$4.68
-$2.51
BBD
▼ -28.01%
Banco Bradesco Sa
Most Active Stocks on Oct. 26: RCT, NU and BBD Top Volume
$2.93
-$1.14
SBS
▼ -26.09%
Companhia de saneamento Basico
$4.73
-$1.67
FAQ — VTRS
Why is VTRS moving today?
VTRS is up 1.61% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.
Is Viatris Inc. a good stock to buy today?
WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.
What is VTRS's average volume?
Average volume for VTRS is approximately 9.22M shares per day based on the trailing 30 sessions.